Openbookopenbook
Equity
Strata Critical Medical, Inc.(SRTA)
USD --+0.00%
Reward53Moderate
Risk35Moderate
📊75%Data
Thin -55% profit margin · Revenue growing 208% YoY
SRTA
+0.0 · +0.00%
USD · NASDAQ
Strata Critical Medical, Inc. | Healthcare
Profitless Growth
Market Cap:369.65M
ℹ️
Reward Rating
53
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
35
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on SRTA to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $9.63.

What is Strata Critical Medical, Inc.?

provides time critical logistics solutions and specialized medical services to healthcare providers across the United States.

SRTA · Verdict

Moderate reward · moderate risk

SRTA stands out on balance sheet and volatility, but watch the profitability signal.

Based on 88% data coverage

SRTA · Verdict

What’s working & what to watch

Strengths 3

  • Balance sheet100/100

    Current ratio 7.07

  • Volatility75/100

    Above average

  • Growth74/100

    Rev +70.1% CAGR · earnings -12.0%

Watchouts 2

  • Profitability9/100

    -11% net margin · -25% ROE

  • Cash flow25/100

    -14% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Strata Critical Medical, Inc.?

provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 369.65M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (53)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap369.65M
P/E RatioN/A
Dividend YieldN/A
52 Week High6.02
52 Week Low2.35
Last AnnualDecember
IPO Date8/28/2025
IncorporatedUSA
Shares Outstanding86M
No. of Employees310
IndustryMedical Care Facilities
ExchangeNASDAQ
Beta-0.21
CurrencyUSD
Websitewww.stratacritical.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.